trending Market Intelligence /marketintelligence/en/news-insights/trending/F_WODYfh-8KVVb9BvaubiQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

AmerisourceBergen fiscal Q3 earnings up 9.1% YOY; FY'19 guidance raised

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


AmerisourceBergen fiscal Q3 earnings up 9.1% YOY; FY'19 guidance raised

AmerisourceBergen Corp. said its adjusted net income for the third quarter ended June 30 rose 9.1% year over year to $371.7 million from $340.6 million.

EPS came in at $1.76, up 14.3% from $1.54 a year earlier.

The S&P Global Market Intelligence consensus normalized EPS estimate in the quarter is $1.62.

The Chesterbrook, Pa.-based healthcare distributor booked a 4.9% yearly increase on its revenue with $45.24 billion from $43.14 billion.

On a GAAP basis, net income climbed 9.5% on an annual basis to $302.0 million, or $1.43 per share, from $275.8 million, or $1.25 per share.

For fiscal year 2019, AmerisourceBergen raised its adjusted EPS outlook in the range of $7.00 to $7.10, from previous guidance in the range of $6.70 to $6.90.

The S&P Global Market Intelligence consensus normalized EPS estimate for the fiscal year is $6.85.